Glioma stem cells (GSCs) are the source of tumor recurrence in glioblastoma and are capable of whole tumor regeneration once the treatment has concluded. Compelling evidence from the last decade suggests that GSC may arise from neural stem cells residing in the adult subventricular zone (SVZ). We report the findings of an 18F-FET PET/CT showing pathological uptake in SVZ with a tumor-background ratio of greater than 1.6, giving evidence for glioblastoma recurrence. This case highlights the particular attention to be paid to the SVZ given the possible development of GSC.

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000003639DOI Listing

Publication Analysis

Top Keywords

18f-fet pet/ct
8
subventricular zone
8
stem cells
8
pet/ct early
4
early subventricular
4
zone recurrence
4
recurrence adult
4
adult glioblastoma
4
glioblastoma glioma
4
glioma stem
4

Similar Publications

Article Synopsis
  • - This study aimed to better understand the role of pre-operative dual-time-point [F]FET PET imaging in characterizing adult-type diffuse gliomas, correlating imaging results with next-generation sequencing data to enhance surgical planning.
  • - Researchers recruited 76 adult patients suspected of having glioma, performing PET scans at two time points after [F]FET injection, and analyzed tumor uptake values and changes alongside histopathological classification and genetic mutations.
  • - Results showed that glioma patients with CDKN2A/B gene loss exhibited significantly higher PET imaging values, indicating more aggressive tumors, while those with PIK3CA mutations showed greater changes in uptake, highlighting the importance of genetic factors in imaging outcomes.
View Article and Find Full Text PDF

Purpose: The accuracy of target delineation in radiation treatment planning of high-grade gliomas (HGGs) is crucial to achieve high tumor control, while minimizing treatment-related toxicity. Magnetic resonance imaging (MRI) represents the standard imaging modality for delineation of gliomas with inherent limitations in accurately determining the microscopic extent of tumors. The purpose of this study was to assess the survival impact of multi-observer delineation variability of multiparametric MRI (mpMRI) and [F]-FET PET/CT.

View Article and Find Full Text PDF

There is a clinical need for F-labeled somatostatin analogs for the imaging of neuroendocrine tumors (NET), given the limitations of using [Ga]Ga-DOTA-peptides, particularly with regard to widespread accessibility. We have shown that [F]fluoroethyl-triazole-[Tyr]-octreotate ([F]FET-βAG-TOCA) has favorable dosimetry and biodistribution. As a step toward clinical implementation, we conducted a prospective, noninferiority study of [F]FET-βAG-TOCA PET/CT compared with [Ga]Ga-DOTA- peptide PET/CT in patients with NET.

View Article and Find Full Text PDF

[The role of PET/CT in the central nervous system tumours].

Magy Onkol

December 2023

Budapesti PET-CT Központ, ScanoMed Orvosi Diagnosztikai, Kutató és Oktató Kft., Budapest, Hungary.

The appearance of hybrid imaging, including PET/CT has been a huge milestone not only in the development of nuclear medicine but of the whole medical imaging. The examination with 18F-FDG, the most frequently used radiopharmaceutical has become for now one of the most important diagnostic tools in oncological patient care, applied with numerous indication goals. However, the depiction of central nervous system malignancies, especially those of the brain, with FDG PET has limitations due to high cerebral background activity, it can be used primarily in lymphoma cases.

View Article and Find Full Text PDF

Prediction of Glioma Grade and IDH Status Using F-FET PET/CT Dynamic and Multiparametric Texture Analysis.

Diagnostics (Basel)

August 2023

Department of Diagnostic and Interventional Radiology, Lausanne University Hospital, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland.

Mutations in isocitrate dehydrogenase (IDH) represent an independent predictor of better survival in patients with gliomas. We aimed to assess grade and IDH mutation status in patients with untreated gliomas, by evaluating the respective value of F-FET PET/CT via dynamic and texture analyses. A total of 73 patients (male: 48, median age: 47) who underwent an F-FET PET/CT for initial glioma evaluation were retrospectively included.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!